Amir Mizbani

Amir Mizbani

Auto-generated profile, based on publicly available information

Amir Mizbani

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Vaccine
Verified
Journal Article
Closed access
AMAmir Mizbani
Amir Mizbani
TTTahereh Taheri
Tahereh Taheri
FZFarnaz Zahedifard
Farnaz Zahedifard
YTYasaman Taslimi
Yasaman Taslimi
HAHiva Azizi
Hiva Azizi
SRSima Rafati
Sima Rafati

29 January 2016 in Stem Cells
Verified
Journal Article
Open access
PDF file
AGArtur Galimov
Artur Galimov
TMTroy L. Merry
Troy L. Merry
ELEdlira Luca
Edlira Luca
ERElisabeth J. Rushing
Elisabeth J. Rushing
AMAmir Mizbani
Amir Mizbani
JKJan Krützfeldt
Jan Krützfeldt
The expansion of myogenic progenitors (MPs) in the adult muscle stem cell niche is critical for the regeneration of skeletal muscle. Activation of quiescent MPs depends on the dismantling of the basement membrane and increased access to growth factors such as fibroblast growth factor-2 (FGF2). Here, we demonstrate using microRNA (miRNA) profiling in mouse and human myoblasts that the capacity of FGF2 to stimulate myoblast proliferation is mediated by miR-29a. FGF2 induces miR-29a expression and inhibition of miR-29a using pharmacological or genetic deletion decreases myoblast proliferation. Next generation RNA sequencing from miR-29a knockout myoblasts (Pax7CE/+; miR-29aflox/flox) identified members of the basement membrane as the most abundant miR-29a targets. Using gain- and loss-of-function experiments, we confirm that miR-29a coordinately regulates Fbn1, Lamc1, Nid2, Col4a1, Hspg2 and Sparc in myoblasts in vitro and in MPs in vivo. Induction of FGF2 and miR-29a and downregulation of its target genes precedes muscle regeneration during cardiotoxin (CTX)-induced muscle injury. Importantly, MP-specific tamoxifen-induced deletion of miR-29a in adult skeletal muscle decreased the proliferation and formation of newly formed myofibers during both CTX-induced muscle injury and after a single bout of eccentric exercise. Our results identify a novel miRNA-based checkpoint of the basement membrane in the adult muscle stem cell niche. Strategies targeting miR-29a might provide useful clinical approaches to maintain muscle mass in disease states such as ageing that involve aberrant FGF2 signaling.

1 December 2017 in Acta Tropica
Verified
Journal Article
Closed access
NMNasrin Masoudzadeh
Nasrin Masoudzadeh
AMAmir Mizbani
Amir Mizbani
YTYasaman Taslimi
Yasaman Taslimi
VMVahid Mashayekhi
Vahid Mashayekhi
HMHossein Mortazavi
Hossein Mortazavi
SRSima Rafati
Sima Rafati

15 November 2016 in Development
Verified
Journal Article
Open access
PDF file
AMAmir Mizbani
Amir Mizbani
ELEdlira Luca
Edlira Luca
ERElisabeth J. Rushing
Elisabeth J. Rushing
JKJan Krützfeldt
Jan Krützfeldt
MicroRNAs (miRNAs) are important regulators of skeletal muscle regeneration, but the underlying mechanisms are still incompletely understood. Here, comparative miRNA sequencing analysis of myogenic progenitor cells (MPs) and non-myogenic fibroblast-adipocyte progenitors (FAPs) during cardiotoxin (CTX)-induced muscle injury uncovered miR-501 as a novel muscle-specific miRNA. miR-501 is an intronic miRNA and its expression levels in MPs correlated with its host gene, chloride channel, voltage-sensitive 5 (Clcn5). Pharmacological inhibition of miR-501 dramatically blunted the induction of embryonic myosin heavy chain (MYH3) and, to a lesser extent, adult myosin isoforms during muscle regeneration, and promoted small-diameter neofibers. An unbiased target identification approach in primary myoblasts validated gigaxonin as a target of miR-501 that mimicked the effect of miR-501 inhibition on MYH3 expression. In the mdx mouse model, which models a pathological disease state, not only was miR-501 induced in regenerating skeletal muscle, but also its serum levels were increased, which correlated with the disease state of the animals. Our results suggest that miR-501 plays a key role in adult muscle regeneration and might serve as a novel serum biomarker for the activation of adult muscle stem cells.

20 July 2016 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
TTTahereh Taheri
Tahereh Taheri
NSNegar Seyed
Negar Seyed
AMAmir Mizbani
Amir Mizbani
SRSima Rafati
Sima Rafati

11 January 2019 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
EGElham Gholami
Elham Gholami
FOFabiano Oliveira
Fabiano Oliveira
TTTahereh Taheri
Tahereh Taheri
NSNegar Seyed
Negar Seyed
SGSafoora Gharibzadeh
Safoora Gharibzadeh
SRSima Rafati
Sima Rafati
The vector-borne disease leishmaniasis is transmitted to humans by infected female sand flies, which transmits Leishmania parasites together with saliva during blood feeding. In Iran, cutaneous leishmaniasis (CL) is caused by Leishmania (L.) major and L. tropica, and their main vectors are Phlebotomus (Ph.) papatasi and Ph. sergenti, respectively. Previous studies have demonstrated that mice immunized with the salivary gland homogenate (SGH) of Ph. papatasi or subjected to bites from uninfected sand flies are protected against L. major infection. In this work we tested the immune response in BALB/c mice to 14 different plasmids coding for the most abundant salivary proteins of Ph. sergenti. The plasmid coding for the salivary protein PsSP9 induced a DTH response in the presence of a significant increase of IFN-γ expression in draining lymph nodes (dLN) as compared to control plasmid and no detectable PsSP9 antibody response. Animals immunized with whole Ph. sergenti SGH developed only a saliva-specific antibody response and no DTH response. Mice immunized with whole Ph. sergenti saliva and challenged intradermally with L. tropica plus Ph. sergenti SGH in their ears, exhibited no protective effect. In contrast, PsSP9-immunized mice showed protection against L. tropica infection resulting in a reduction in nodule size, disease burden and parasite burden compared to controls. Two months post infection, protection was associated with a significant increase in the ratio of IFN-γ to IL-5 expression in the dLN compared to controls. This study demonstrates that while immunity to the whole Ph. sergenti saliva does not induce a protective response against cutaneous leishmaniasis in BALB/c mice, PsSP9, a member of the PpSP15 family of Ph. sergenti salivary proteins, provides protection against L. tropica infection. These results suggest that this family of proteins in Ph. sergenti, Ph. duboscqi and Ph. papatasi may have similar immunogenic and protective properties against different Leishmania species. Indeed, this anti-saliva immunity may act as an adjuvant to accelerate the cell-mediated immune response to co-administered Leishmania antigens, or even cause the activation of infected macrophages to remove parasites more efficiently. These findings highlight the idea of applying arthropod saliva components in vaccination approaches for diseases caused by vector-borne pathogens. Leishmaniasis is a vector-borne disease transmitted to humans by an infected sand fly bite, through which Leishmania parasites and saliva are co-delivered into the host skin. Despite the numerous studies performed in this area, no vaccine is yet available to control this neglected disease in humans. During the past two decades, saliva of sand flies has been tested for possible application as a vaccine against leishmaniasis. Exposure to specific salivary proteins or sand fly bites can induce a protective cell-mediated immunity. Immunization with Ph. papatasi saliva or recombinant PpSP15 has been previously reported to provide protection against L. major infection. In this study, the efficiency of immunization with Ph. sergenti saliva or plasmid coding for Ph. sergenti salivary proteins in protecting the BALB/c mice against L. tropica was explored. Here we show that although immunization with whole saliva induces a humoral response, this immune response is unable to protect mice against infection; in contrast, immunization with a plasmid coding for Ph. sergenti PsSP9 salivary protein induces a Th1 immune response characterized by a strong DTH response, no detectable antibody response, and a high expression ratio of IFN-γ to IL-5 in lymph nodes. The Th1 induced immunity in PsSP9-immunized mice correlates with the protection observed against infection with L. tropica, which was associated with a significant reduction in ear thickness and decrease in parasite load in the ear of protected animals in comparison to control group. Our data suggest that instead of using the whole sand fly salivary proteins, a more effective approach is the use of a single Ph. sergenti salivary protein.